Taken together, these lung cancer studies of CYP2A6 genotype, P450 2A6 metabolism, and total nicotine equivalents confirm the relationship of CYP2A6 genotype to lung cancer risk in individual smokers independent of their racial/ethnic identity (Fig. 2). The gene discussed is CYP2A6; the disease is lung carcinoma.